NCT01249846

CompletedPhase 3

The Efficacy and Safety of 2.5 mg Chlorhexidine Gluconate Ch...

Dexcel Pharma Technologies Ltd.Source

Compare

Other study identifiers

Sponsor study identifier

CLI/015P

Study Type

interventional

Reported enrollment (type unavailable)

N/A

Locations

1 country

Sites

1

Timeline

Study Start

December 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

Not reported

Date not reported

Brief Summary

The purpose of this study is to assess the efficacy and the safety of Chlorhexidine Gluconate Chip (PerioChip®) in frequent treatment versus routine treatment in therapy of adult chronic periodontitis.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): Not reported
Study completion date: Not reported
Date not reported
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
November 28, 2010
Actual (reported)
First Posted
November 30, 2010
Actual (reported)
Study Start
December 2010
Date type not reported
This date has not been verified as actual or estimated.

Last Updated: January 17, 2013
Status Verified: January 2013
Last Update Submitted: January 16, 2013

Conditions

Generalized Adult Periodontitis

Study Arms (2)

Arm 1

EXPERIMENTAL

Each one of the two selected periodontal pockets (target pockets) will be randomized to the Frequent PerioChip® treatment or to the Routine PerioChip®.

Drug: PerioChip ®

Arm 2

PLACEBO COMPARATOR

Each one of the two selected target pockets will be randomized to the Frequent PerioChip® treatment or to the Frequent Placebo Chip treatment.

Drug: PerioChip ®

Interventions

PerioChip ®Drug

Arm 1Arm 2

Eligibility Criteria

Age21 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Signed and dated Informed Consent Form.
Good general health.

Sponsors & Collaborators

Dexcel Pharma Technologies Ltd.
Industrylead

Study Sites (1)

Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Center

Haifa, 9602, Israel

MeSH Terms

Interventions

Chlorhexidine

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic Chemicals

Study Design

Study Type: interventional
Phase: phase 3
Purpose: TREATMENT
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

November 28, 2010

First Posted

November 30, 2010

Study Start

December 2010

Date type not reported

This date has not been verified as actual or estimated.

Last Updated

January 17, 2013

Record last verified: 2013-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01249846
Data provider: ClinicalTrials.gov
Source updated: 2013-01-17
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:40:27 UTC

NCT02639377

Efficacy of 0.12% Chlorhexidine Gluconate for Peri-implant Mucositis and Gingivitis

Phase 2Completed

NCT00859235

The Influence of Oral Hygiene on Local Wound and Systemic Infection in Patients With Percutaneous Endoscopic Gastrostomy Placement

Phase 3Unknown

NCT00528008

A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections

Phase 3Terminated

NCT02446158

Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients

Phase 4Completed

NCT02423304

Serological Evaluation of 77A/G and 11A/12A Gene of MMP-13 in Periodontitis Affected and Healthy Individuals

Unknown

NCT02915289

Chlorhexidine Gluconate vs Povidone-Iodine Vaginal Cleansing Solution Prior to Cesarean Delivery

Phase 3Completed

Male or female patients aged \>21 years old.

Availability for the 25 week duration of the study.

Chronic periodontal disease on natural teeth

Females of childbearing potential must be non-pregnant and non-lactating at entry and agree to use an adequate method of birth control during the study.

You may not qualify if:

Oral health or factor that may influence the outcome of the study.
History of allergy to Chlorhexidine .
Patient uses Chlorhexidine oral rinses/mouthwashes on a regular basis.
Patients treated with medications that may influence the outcome of the study.
Presence of any of the following conditions: Type 1 diabetes, un-controlled type II diabetes, major recurrent aphtae stomatitis, abscesses and related oral pathologies.
The presence of any medical or psychiatric condition or any other condition that, in the opinion of the Investigator, could affect the successful participation of the patient in the study.
Patient participates in any other clinical study 30 days prior to the start of the study and throughout the study duration.

Contact the study team to confirm eligibility.

Locations

IL(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Conditions

Study Arms (2)

Arm 1

Arm 2

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record

You may not qualify if:

Locations